How This New Biotech Billionaire Outmaneuvered Merck In China
- Author
- Forbes
- Published
- Wed 23 Jul 2025
- Episode Link
- None
Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best seller–and its surging stock just made her a billionaire.
